Mr. Shane Bishop reports

CUSTOM HEALTH CLOSES PUBLIC OFFERING

Custom Health Holdings Inc. has closed its previously announced public offering of units of the company. Pursuant to the offering, the company issued 2,088,514 units at a price per unit of $4.95 for aggregate gross proceeds of $10,338,144.30. Each unit consists of one common share of the company and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one common share at an exercise price of $5.90 for a period of 60 months. The offering was completed through Stifel Nicolaus Canada Inc. as lead agent and sole bookrunner.

The units were offered in all provinces and territories of Canada other than Quebec pursuant to a prospectus supplement dated Nov. 11, 2026, pursuant to the company's short form base shelf prospectus dated Nov. 5, 2026.

The net proceeds of the offering will be used to finance the company's initiatives, including to finance payments in relation to previously announced acquisitions and associated transaction costs, and to finance planned debt repayments, general and administrative expenses, and working capital all as further described in and subject to the prospectus supplement.

The agent also offered the units in the United States or to, or for the account or benefit of, a U.S. person (as defined in Regulation S under the U.S. Securities Act of 1933, as amended) on a private placement basis to accredited investors (as defined in Rule 501 of Regulation D under the 1933 act) and to qualified institutional buyers (as defined in Rule 144A under the 1933 act) who are also accredited investors, in each case pursuant to an applicable exemption from registration offered by Rule 506(b) of Regulation D and/or Section 4(a)(2) under the 1933 act and in compliance with applicable state securities laws.

Shane Bishop, chief executive officer and director of the company, participated in the offering by acquiring 282,830 units for an aggregate gross purchase price of $1,400,008.50. Mr. Bishop's participation in the offering constituted a related-party transaction as defined under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). The company is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 as neither the fair market value of the securities issued to, nor the consideration to be paid by, Mr. Bishop exceeded 25 per cent of the company's market capitalization, as determined in accordance with MI 61-101. Further details regarding any insider participation will be included in the company's material change report to be filed in connection with the offering. The material change report will be filed fewer than 21 days before the closing date of the offering, which the company considers reasonable in the circumstances to complete the offering in a timely manner.

The common shares comprising the units have been listed on the Toronto Stock Exchange, and the common shares underlying the warrants and the warrants issued to the agent have been conditionally approved for listing on the TSX. The company will use best efforts to list the warrants on the TSX at a later date subject to TSX approval and compliance with TSX policies; however, there is no guarantee that any such listing will occur or the timing of such listing.

Copies of the prospectus supplement and base shelf prospectus are available under the company's profile on SEDAR+. Alternatively, the prospectus supplement and the base shelf prospectus may be obtained free of charge upon request by contacting the company at 1631 Dickson Ave., Suite 900, Kelowna, B.C., V1Y 0B5, or by e-mail at ir@customhealth.com.

About Custom Health Holdings Inc.

Custom Health is an artificial-intelligence-enabled health care technology company that is building the infrastructure for medication management at home. The company connects in-home technology, pharmacy and pharmacist-led clinicians to create continuous visibility into a patient's medication use and support timely clinical action. Powered by the proprietary AdhereNet platform, Custom Health operates an integrated pharmacy network across Canada and the United States as part of its broader infrastructure, supporting medication delivery, medication use insights and pharmacist-led care to enable earlier intervention and better medication management at home.

We seek Safe Harbor.